Andrew Teasdale

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakes
  Regulatory Toxicology and Pharmacology 2025 DOI: 10.1016/j.yrtph.2024.105762
  +Save
• Regulatory Highlights
  Organic Process Research & Development 2024 DOI: 10.1021/acs.oprd.4c00492
  +Save
• Regulatory Highlights
  Organic Process Research & Development 2024 DOI: 10.1021/acs.oprd.4c00341
  +Save
• Leveraging ICH M7 Control Options 3 and 4: Discussion and Clarification Using Industrial Case Studies
  Organic Process Research & Development 2024 DOI: 10.1021/acs.oprd.4c00207
  +Save
• Regulatory Highlights
  Organic Process Research & Development 2024 DOI: 10.1021/acs.oprd.4c00055
  +Save
• Revisiting the Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals
  Journal of Pharmaceutical Sciences 2023 DOI: 10.1016/j.xphs.2023.10.001
  +Save
• Reflections on the Impact of Nitrosamine Drug Substance Related Impurities
  Organic Process Research & Development 2023 DOI: 10.1021/acs.oprd.3c00286
  +Save
• Regulatory Highlights
  Organic Process Research & Development 2023 DOI: 10.1021/acs.oprd.3c00278
  +Save
• The Nitrosamine “Saga”: Lessons Learned from Five Years of Scrutiny
  Organic Process Research & Development 2023 DOI: 10.1021/acs.oprd.3c00100
  +Save